Vitamin A and Retinoids as Mitochondrial Toxicants

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  De Oliveira, Marcos Roberto ^a  

^a FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MOBILE SECURITY; NUTRIENTS; TRACE ELEMENTS;

CELLULAR FUNCTION; CLINICAL APPLICATION; DELETERIOUS EFFECTS; HUMAN DEVELOPMENT; LIFE QUALITIES; MITOCHONDRIAL DYSFUNCTION; MITOCHONDRIAL FUNCTION; MORTALITY RATE;

DISEASES;

CELLULAR RETINOL BINDING PROTEIN; CELLULAR RETINOL BINDING PROTEIN 11; RETINOID; RETINOL; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CELL FUSION; CELL MEMBRANE POTENTIAL; CELL ORGANELLE; CELL PROLIFERATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EX VIVO STUDY; HUMAN; HYDROPHOBICITY; IN VIVO STUDY; LIPID PEROXIDATION; MEMBRANE STRUCTURE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION SWELLING; NERVE CELL PLASTICITY; NONHUMAN; OXIDATION; PROTEIN CARBONYLATION; QUALITY OF LIFE; RETINOL INTOXICATION; REVIEW; VITAMIN METABOLISM; ANIMAL; DRUG EFFECTS; MAMMAL; METABOLISM; MITOCHONDRION; PATHOLOGY;

ANIMALS; HUMANS; HYPERVITAMINOSIS A; MAMMALS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; RETINOIDS; VITAMIN A;

EID: 84930958553     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/140267     Document Type: Review

References (141)

1. D. A. Ross, "Recommendations for vitamin A supplementation,"Journal of Nutrition, vol. 131, pp. 2902S-2906S, 2002.
2. S. A. Tanumihardjo, "Assessing vitamin A status: past, present and future," The Journal of Nutrition, vol. 134, no. 1, pp. 290S-293S, 2004.
3. L. H. Allen and M. Haskell, "Estimating the potential for vitamin A toxicity in women and young children," Journal of Nutrition, vol. 132, no. 9, pp. 2907S-2919S, 2002.
4. P. P. Glasziou and D. E. M. Mackerras, "Vitamin A supplementation in infectious diseases: a meta-analysis," British Medical Journal, vol. 306, no. 6874, pp. 366-370, 1993.
5. H. Tsutani, H. Iwasaki, Y. Kawai et al., "Reduction of leukemia cell growth in a patient with acute promyelocytic leukemia treated by retinol palmitate," Leukemia Research, vol. 14, no. 7, pp. 595-600, 1990.
6. H. Tsutani, T. Ueda, M. Uchida, and T. Nakamura, "Pharmacological studies of retinol palmitate and its clinical effect in patients with acute non-lymphocytic leukemia," Leukemia Research, vol. 15, no. 6, pp. 463-471, 1991.
7. P. Fenaux, C. Chomienne, and L. Degos, "Treatment of acute promyelocytic leukaemia," Best Practice and Research: Clinical Haematology, vol. 14, no. 1, pp. 153-174, 2001.
8. A. M. Myhre, M. H. Carlsen, S. K. Bohn, H. L. Wold, P. Laake, and R. Blomhoff, "Water-miscible, emulsified, and solid forms of retinol supplements are more toxic than oil-based preparations,"American Journal of Clinical Nutrition, vol. 78, no. 6, pp. 1152-1159, 2003.
9. K. O'Reilly, S. J. Bailey, and M. A. Lane, "Retinoid-mediated regulation of mood: possible cellular mechanisms," Experimental Biology and Medicine, vol. 233, no. 3, pp. 251-258, 2008.
10. H. Mactier and L. T. Weaver, "Vitamin A and preterm infants: what we know, what we don't know, and what we need to know,"Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 90, no. 2, pp. F103-F108, 2005.
11. A. B. Fisker, C. Bale, A. Rodrigues et al., "High-dose vitamin A with vaccination after 6 months of age: a randomized trial,"Pediatrics, vol. 134, no. 3, pp. e739-e748, 2014.
12. C. A. van Loo-Bouwman, T. H. J. Naber, and G. Schaafsma, "A review of vitamin A equivalency of β-carotene in various food matrices for human consumption," The British Journal of Nutrition, vol. 111, no. 12, pp. 2153-2166, 2014.
13. S. R. Snodgrass, "Vitamin neurotoxicity," Molecular Neurobiology, vol. 6, no. 1, pp. 41-73, 1992.
14. J. L. Napoli, "Retinoic acid: its biosynthesis and metabolism,"Progress in Nucleic Acid Research and Molecular Biology, vol. 63, pp. 139-188, 1999.
15. J. L. Napoli, "Physiological insights into all-trans-retinoic acid biosynthesis," Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids, vol. 1821, no. 1, pp. 152-167, 2012.
16. V. P. Palace, N. Khaper, Q. Qin, and P. K. Singal, "Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease," Free Radical Biology and Medicine, vol. 26, no. 5-6, pp. 746-761, 1999.
17. Y. Li, N. Wongsiriroj, and W. S. Blaner, "The multifaceted nature of retinoid transport and metabolism," Hepatobiliary Surgery and Nutrition, vol. 3, no. 3, pp. 126-139, 2014.
18. A. Piskunov, Z. Al Tanoury, and C. Rochette-Egly, "Nuclear and extra-nuclear effects of retinoid acid receptors: how they are interconnected," in The Biochemistry of Retinoic Acid Receptors I: Structure, Activation, and Function at the Molecular Level, vol. 70 of Subcellular Biochemistry, pp. 103-127, Springer, Dordrecht, The Netherlands, 2014.
19. R. M. Evans and D. J. Mangelsdorf, "Nuclear receptors, RXR, and the big bang," Cell, vol. 157, no. 1, pp. 255-266, 2014.
20. J. von Lintig, "Provitamin A metabolism and functions in mammalian biology," American Journal of Clinical Nutrition, vol. 96, no. 5, pp. 1234S-1244S, 2012.
21. T. Moore, "Vitamin A and carotene: VI. The conversion of carotene to vitamin A in vivo," Biochemical Journal, vol. 24, no. 3, pp. 692-702, 1930.
22. K. Palczewski, "G protein-coupled receptor rhodopsin," Annual Review of Biochemistry, vol. 75, pp. 743-767, 2006.
23. J. von Lintig, P. D. Kiser, M. Golczak, and K. Palczewski, "The biochemical and structural basis for trans-to-cis isomerization of retinoids in the chemistry of vision," Trends in Biochemical Sciences, vol. 35, no. 7, pp. 400-410, 2010.
24. J. A. Olson and D. Gunning, "The storage form of vitamin A in rat liver cells," Journal of Nutrition, vol. 113, no. 11, pp. 2184-2191, 1983.
25. E. Reboul, "Absorption of vitamin A and carotenoids by the enterocyte: focus on transport proteins," Nutrients, vol. 5, no. 9, pp. 3563-3581, 2013.
26. P. Borel, "Factors affecting intestinal absorption of highly lipophilic food microconstituents (fat-soluble vitamins, carotenoids and phytosterols)," Clinical Chemistry and Laboratory Medicine, vol. 41, no. 8, pp. 979-994, 2003.
27. V. Tyssandier, E. Reboul, J.-F. Dumas et al., "Processing of vegetable-borne carotenoids in the human stomach and duodenum,"American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 284, no. 6, pp. G913-G923, 2003.
28. P. Borel, B. Pasquier, M. Armand et al., "Processing of vitamin A and E in the human gastrointestinal tract," American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 280, no. 1, pp. G95-G103, 2001.
29. F. Carrière, J. A. Barrowman, R. Verger, and R. Laugier, "Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans," Gastroenterology, vol. 105, no. 3, pp. 876-888, 1993.
30. D. Lombardo and O. Guy, "Studies on the substrate specificity of a carboxyl ester hydrolase from human pancreatic juice. II. Action on cholesterol esters and lipid-soluble vitamin esters,"Biochimica et Biophysica Acta, vol. 611, no. 1, pp. 147-155, 1980.
31. H. A. Zahalka, S. C. Cheng, G. W. Burton, and K. U. Ingold, "Hydrolysis of stereoisomeric alpha-tocopheryl acetates catalyzed by bovine cholesterol esterase," Biochimica et Biophysica Acta - Lipids and Lipid Metabolism, vol. 921, no. 3, pp. 481-485, 1987.
32. C. Lauridsen, M. S. Hedemann, and S. K. Jensen, "Hydrolysis of tocopheryl and retinyl esters by porcine carboxyl ester hydrolase is affected by their carboxylate moiety and bile acids,"Journal of Nutritional Biochemistry, vol. 12, no. 4, pp. 219-224, 2001.
33. B. Sivakumar and V. Reddy, "Absorption of labelled vitamin A in children during infection," British Journal of Nutrition, vol. 27, no. 2, pp. 299-304, 1972.
34. M. E. O'Neill and D. I. Thurnham, "Intestinal absorption of β-carotene, lycopene and lutein in men and women following a standard meal: response curves in the triacylglycerol-rich lipoprotein fraction," British Journal of Nutrition, vol. 79, no. 2, pp. 149-159, 1998.
35. J. A. Novotny, S. R. Dueker, L. A. Zech, and A. J. Clifford, "Compartmental analysis of the dynamics of β-carotene metabolism in an adult volunteer," Journal of Lipid Research, vol. 36, no. 8, pp. 1825-1838, 1995.
36. T. van Vliet, W. H. P. Schreurs, and H. van den Berg, "Intestinal β-carotene absorption and cleavage in men: response of β-carotene and retinyl esters in the triglyceride-rich lipoprotein fraction after a single oral dose of β-carotene," The American Journal of Clinical Nutrition, vol. 62, no. 1, pp. 110-116, 1995.
37. M. van Lieshout, C. E. West, and R. B. van Breemen, "Isotopic tracer techniques for studying the bioavailability and bioefficacy of dietary carotenoids, particularly β-carotene, in humans: a review," The American Journal of Clinical Nutrition, vol. 77, no. 1, pp. 12-28, 2003.
38. R. M. Faulks, D. J. Hart, P. D. G. Wilson, K. J. Scott, and S. Southon, "Absorption of all-trans and 9-cis β-carotene in human ileostomy volunteers," Clinical Science, vol. 93, no. 6, pp. 585-591, 1997.
39. T. C. Quick and D. E. Ong, "Vitamin A metabolism in the human intestinal Caco-2 cell line," Biochemistry, vol. 29, no. 50, pp. 11116-11123, 1990.
40. R. Kawaguchi, J. Yu, J. Honda et al., "A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A,"Science, vol. 315, no. 5813, pp. 820-825, 2007.
41. D. Hollander and P. E. Ruble Jr., "beta-carotene intestinal absorption: bile, fatty acid, pH, and flow rate effects on transport,"The American Journal of Physiology, vol. 235, no. 6, pp. E686-691, 1978.
42. P. Sauvant, N. Mekki, M. Charbonnier, H. Portugal, D. Lairon, and P. Borel, "Amounts and types of fatty acids in meals affect the pattern of retinoids secreted in human chylomicrons after a high-dose preformed vitamin A intake," Metabolism: Clinical and Experimental, vol. 52, no. 4, pp. 514-519, 2003.
43. J. J. M. Castenmiller and C. E. West, "Bioavailability and bioconversion of carotenoids," Annual Review of Nutrition, vol. 18, pp. 19-38, 1998.
44. J. L. Napoli, "Retinoic acid biosynthesis and metabolism,"FASEB Journal, vol. 10, no. 9, pp. 993-1001, 1996.
45. N. Noy, "Retinoid-binding proteins: mediators of retinoid action," Biochemical Journal, vol. 348, no. 3, pp. 481-495, 2000.
46. R. H. Zetterstrom, "Localization of cellular retinoid-binding proteins suggests specific roles for retinoids in the adult central nervous system," Neuroscience, vol. 62, no. 3, pp. 899-918, 1994.
47. R. Blomhoff and H. K. Blomhoff, "Overview of retinoid metabolism and function," Journal of Neurobiology, vol. 66, no. 7, pp. 606-630, 2006.
48. M. N. Vergara, Y. Arsenijevic, and K. del Rio-Tsonis, "CNS regeneration: a morphogen's tale," Journal of Neurobiology, vol. 64, no. 4, pp. 491-507, 2005.
49. P. McCaffery and U. C. Drager, "High levels of a retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system," Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 16, pp. 7772-7776, 1994.
50. W. Kręzel, N. Ghyselinck, T. A. Samad et al., "Impaired locomotion and dopamine signaling in retinoid receptormutant mice,"Science, vol. 279, no. 5352, pp. 863-867, 1998.
51. S. Urano, Y. Inomori, T. Sugawara et al., "Vitamin E: inhibition of retinol-induced hemolysis and membrane-stabilizing behavior,"Journal of Biological Chemistry, vol. 267, no. 26, pp. 18365-18370, 1992.
52. S. Krishnamurthy, T. George, and N. J. Bai, "Hydroxy radical involvement in retinol hemolysis of human erythrocytes in vitro," Indian Journal of Biochemistry and Biophysics, vol. 21, no. 6, pp. 397-399, 1984.
53. A. H. Goodall, D. Fisher, and J. A. Lucy, "Cell fusion, haemolysis and mitochondrial swelling induced by retinol and derivatives,"Biochimica et Biophysica Acta, vol. 595, no. 1, pp. 9-14, 1980.
54. C. J. Hogan, J. S. Wiley, and T. Billington, "Intravascular haemolysis complicating treatment of acute promyelocytic leukaemia with all-trans retinoic acid (ATRA)," Australian and New Zealand Journal of Medicine, vol. 27, no. 4, pp. 450-451, 1997.
55. M. P. Rigobello, G. Scutari, A. Friso, E. Barzon, S. Artusi, and A. Bindoli, "Mitochondrial permeability transition and release of cytochrome c induced by retinoic acids," Biochemical Pharmacology, vol. 58, no. 4, pp. 665-670, 1999.
56. D. R. Green, L. Galluzzi, and G. Kroemer, "Metabolic control of cell death," Science, vol. 345, no. 6203, Article ID1250256, 2014.
57. F. Klamt, M. R. de Oliveira, and J. C. F. Moreira, "Retinol induces permeability transition and cytochrome c release from rat liver mitochondria," Biochimica et Biophysica Acta: General Subjects, vol. 1726, no. 1, pp. 14-20, 2005.
58. F. Klamt, F. dal-Pizzol, D. P. Gelain et al., "Vitamin A treatment induces apoptosis through an oxidant-dependent activation of the mitochondrial pathway," Cell Biology International, vol. 32, no. 1, pp. 100-106, 2008.
59. F. S. G. Silva, M. P. C. Ribeiro, M. S. Santos, P. Rocha-Pereira, A. Santos-Silva, and J. B. A. Custódio, "Acitretin affects bioenergetics of liver mitochondria and promotes mitochondrial permeability transition: potential mechanisms of hepatotoxicity,"Toxicology, vol. 306, pp. 93-100, 2013.
60. O. Sawada, L. Perusek, H. Kohno et al., "All-trans-retinal induces Bax activation via DNA damage to mediate retinal cell apoptosis," Experimental Eye Research, vol. 123, pp. 27-36, 2014.
61. A. Maeda, T. Maeda, M. Golczak, and K. Palczewski, "Retinopathy in mice induced by disrupted all-trans-retinal clearance,"Journal of Biological Chemistry, vol. 283, no. 39, pp. 26684-26693, 2008.
62. H. El Hajj, B. Khalil, B. Ghandour et al., "Preclinical efficacy of the synthetic retinoid ST1926 for treating adult T-cell leukemia/lymphoma," Blood, vol. 124, no. 13, pp. 2072-2080, 2014.
63. M. R. de Oliveira, R. B. Silvestrin, T. Mello E Souza, and J. C. F. Moreira, "Oxidative stress in the hippocampus, anxiety-like behavior and decreased locomotory and exploratory activity of adult rats: effects of sub acute vitamin A supplementation at therapeutic doses," NeuroToxicology, vol. 28, no. 6, pp. 1191-1199, 2007.
64. M. R. de Oliveira, M. A. de Bittencourt Pasquali, R. B. Silvestrin, T. Mello e Souza, and J. C. F. Moreira, "Vitamin A supplementation induces a prooxidative state in the striatum and impairs locomotory and exploratory activity of adult rats,"Brain Research, vol. 1169, no. 1, pp. 112-119, 2007.
65. M. R. de Oliveira and J. C. F. Moreira, "Acute and chronic vitamin A supplementation at therapeutic doses induces oxidative stress in submitochondrial particles isolated from cerebral cortex and cerebellum of adult rats," Toxicology Letters, vol. 173, no. 3, pp. 145-150, 2007.
66. M. R. de Oliveira, R. B. Silvestrin, T. Mello e Souza, and J. C. F. Moreira, "Therapeutic vitamin A doses increase the levels of markers of oxidative insult in substantia nigra and decrease locomotory and exploratory activity in rats after acute and chronic supplementation," Neurochemical Research, vol. 33, no. 3, pp. 378-383, 2008.
67. M. R. de Oliveira, M. W. S. Oliveira, G. A. Behr, M. L. M. Hoff, R. F. da Rocha, and J. C. F. Moreira, "Evaluation of the effects of vitamin A supplementation on adult rat substantia nigra and striatum redox and bioenergetic states: mitochondrial impairment, increased 3-nitrotyrosine and alphasynuclein, but decreased D2 receptor contents," Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 33, no. 2, pp. 353-362, 2009.
68. M. R. De Oliveira, M. W. S. Oliveira, R. F. Da Rocha, and J. C. F. Moreira, "Vitamin A supplementation at pharmacological doses induces nitrosative stress on the hypothalamus of adult Wistar rats," Chemico-Biological Interactions, vol. 180, no. 3, pp. 407-413, 2009.
69. M. R. de Oliveira, M. W. S. Oliveira, G. A. Behr, and J. C. F. Moreira, "Vitamin A supplementation at clinical doses induces a dysfunction in the redox and bioenergetics states, but did change neither caspases activities nor TNF-α levels in the frontal cortex of adult Wistar rats," Journal of Psychiatric Research, vol. 43, no. 8, pp. 754-762, 2009.
70. M. R. deOliveira, R. F. daRocha, and J. C. F. Moreira, "Increased susceptibility of mitochondria isolated from frontal cortex and hippocampus of vitamin A-treated rats to non-aggregated amyloid-β peptides 1-40 and 1-42," Acta Neuropsychiatrica, vol. 24, no. 2, pp. 101-108, 2012.
71. M. R. de Oliveira, R. F. da Rocha, L. Stertz et al., "Total and mitochondrial nitrosative stress, decreased brain-derived neurotrophic factor (BDNF) levels and glutamate uptake, and evidence of endoplasmic reticulum stress in the hippocampus of vitamin A-treated rats," Neurochemical Research, vol. 36, no. 3, pp. 506-517, 2011.
72. M. R. de Oliveira, M. W. Soares Oliveira, M. L. Müller Hoff, G. A. Behr, R. F. da Rocha, and J. C. Fonseca Moreira, "Evaluation of redox and bioenergetics states in the liver of vitamin Atreated rats," European Journal of Pharmacology, vol. 610, no. 1-3, pp. 99-105, 2009.
73. M. R. de Oliveira, M. W. S. Oliveira, R. Lorenzi, R. Fagundes da Rocha, and J. C. Fonseca Moreira, "Short-term vitamin A supplementation at therapeutic doses induces a pro-oxidative state in the hepatic environment and facilitates calcium-ion-induced oxidative stress in rat liver mitochondria independently from permeability transition pore formation: detrimental effects of vitamin A supplementation on rat liver redox and bioenergetic states homeostasis," Cell Biology and Toxicology, vol. 25, no. 6, pp. 545-560, 2009.
74. R. F. da Rocha, M. R. de Oliveira, P. Schonhofen, C. E. Schnorr, F. Dal Pizzol, and J. C. F. Moreira, "Long-term vitamin A supplementation at therapeutic doses induces mitochondrial electrons transfer chain (METC) impairment and increased mitochondrial membrane-enriched fraction (MMEF) 3-nitrotyrosine on rat heart," Free Radical Research, vol. 44, no. 5, pp. 505-512, 2010.
75. M. A. de Bittencourt Pasquali, M. R. de Oliveira, M. A. de Bastiani et al., "L-NAME co-treatment prevent oxidative damage in the lung of adult Wistar rats treated with vitamin A supplementation," Cell Biochemistry and Function, vol. 30, no. 3, pp. 256-263, 2012.
76. M. R. de Oliveira and J. C. F. Moreira, "Impaired redox state and respiratory chain enzyme activities in the cerebellum of vitamin A-treated rats," Toxicology, vol. 253, no. 1-3, pp. 125-130, 2008.
77. M. R. de Oliveira, R. F. da Rocha, C. E. Schnorr, and J. C. F. Moreira, "L-NAME cotreatment did prevent neither mitochondrial impairment nor behavioral abnormalities in adult Wistar rats treated with vitamin A supplementation," Fundamental and Clinical Pharmacology, vol. 26, no. 4, pp. 513-529, 2012.
78. M. R. de Oliveira, R. Lorenzi, C. E. Schnorr, M. Morrone, and J. C. F. Moreira, "Increased 3-nitrotyrosine levels in mitochondrial membranes and impaired respiratory chain activity in brain regions of adult female rats submitted to daily vitamin A supplementation for 2 months," Brain Research Bulletin, vol. 86, no. 3-4, pp. 246-253, 2011.
79. V. G. Grivennikova and A. D. Vinogradov, "Generation of superoxide by the mitochondrial complex I," Biochimica et Biophysica Acta, vol. 1757, no. 5-6, pp. 553-561, 2006.
80. A. Y. Andreyev, Y. E. Kushnareva, and A. A. Starkov, "Mitochondrial metabolism of reactive oxygen species," Biochemistry, vol. 70, no. 2, pp. 200-214, 2005.
81. M. R. de Oliveira, M. W. S. Oliveira, and J. C. F. Moreira, "Pharmacological doses of vitamin A increase caspase-3 activity selectively in cerebral cortex," Fundamental & Clinical Pharmacology, vol. 24, no. 4, pp. 445-450, 2010.
82. R. Radi, "Peroxynitrite, a stealthy biological oxidant," The Journal of Biological Chemistry, vol. 288, no. 37, pp. 26464-26472, 2013.
83. S. Carballal, S. Bartesaghi, and R. Radi, "Kinetic and mechanistic considerations to assess the biological fate of peroxynitrite,"Biochimica et Biophysica Acta, vol. 1840, no. 2, pp. 768-780, 2014.
84. B. I. Giasson, J. E. Duda, I. V. J. Murray et al., "Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions," Science, vol. 290, no. 5493, pp. 985-989, 2000.
85. J. M. Souza, B. I. Giasson, Q. Chen, V. M.-Y. Lee, and H. Ischiropoulos, "Dityrosine cross-linking promotes formation of stable α-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies,"The Journal of Biological Chemistry, vol. 275, no. 24, pp. 18344-18349, 2000.
86. J. P. Eiserich, A. G. Estévez, T. V. Bamberg, P. H. Chumley, J. S. Beckman, and B. A. Freeman, "Microtubule dysfunction by posttranslational nitrotyrosination of α-tubulin: a nitric oxidedependent mechanism of cellular injury," Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 11, pp. 6365-6370, 1999.
87. B. Halliwell, "Oxidative stress and neurodegeneration: where are we now?" Journal of Neurochemistry, vol. 97, no. 6, pp. 1634-1658, 2006.
88. A. Bir, O. Sen, S. Anand et al., "α-synuclein-induced mitochondrial dysfunction in isolated preparation and intact cells: implications in the pathogenesis of Parkinson's disease," Journal of Neurochemistry, vol. 131, no. 6, pp. 868-877, 2014.
89. M. Robotta, H. R. Gerding, A. Vogel et al., "Alpha-synuclein binds to the inner membrane of mitochondria in an α-helical conformation," ChemBioChem, vol. 15, no. 17, pp. 2499-2502, 2014.
90. 2 challenge,"Brain Research Bulletin, vol. 87, no. 4-5, pp. 432-444, 2012.
91. D. E. Edmondson, "Hydrogen peroxide produced by mitochondrial monoamine oxidase catalysis: biological implications,"Current Pharmaceutical Design, vol. 20, no. 2, pp. 155-160, 2014.
92. A. Boveris and B. Chance, "The mitochondrial generation of hydrogen peroxide," Biochemical Journal, vol. 134, no. 3, pp. 707-716, 1973.
93. E. A. Veal, A. M. Day, and B. A. Morgan, "Hydrogen peroxide sensing and signaling," Molecular Cell, vol. 26, no. 1, pp. 1-14, 2007.
94. M. Reth, "Hydrogen peroxide as second messenger in lymphocyte activation," Nature Immunology, vol. 3, no. 12, pp. 1129-1134, 2002.
95. S. G. Rhee, S. W. Kang, W. Jeong, T.-S. Chang, K.-S. Yang, and H. A. Woo, "Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins," Current Opinion in Cell Biology, vol. 17, no. 2, pp. 183-189, 2005.
96. J. R. Stone and S. Yang, "Hydrogen peroxide: a signaling messenger," Antioxidants and Redox Signaling, vol. 8, no. 3-4, pp. 243-270, 2006.
97. B. Halliwell, "Free radicals and antioxidants: updating a personal view," Nutrition Reviews, vol. 70, no. 5, pp. 257-265, 2012.
98. Y. Kono and I. Fridovich, "Superoxide radical inhibits catalase,"The Journal of Biological Chemistry, vol. 257, no. 10, pp. 5751-5754, 1982.
99. D. F. A. R. Dourado, P. A. Fernandes, and M. J. Ramos, "Mammalian cytosolic glutathione transferases," Current Protein and Peptide Science, vol. 9, no. 4, pp. 325-337, 2008.
100. K. Rashid, K. Sinha, and P. C. Sil, "An update on oxidative stress-mediated organ pathophysiology," Food and Chemical Toxicology, vol. 62, pp. 584-600, 2013.
101. T. Szkudelski, M. Okulicz, I. Bialik, and K. Szkudelska, "The influence of fasting on liver sulfhydryl groups, glutathione peroxidase and glutathione-S-transferase activities in the rat,"Journal of Physiology and Biochemistry, vol. 60, no. 1, pp. 1-6, 2004.
102. J. Sian-Hülsmann, S. Mandel, M. B. H. Youdim, and P. Riederer, "The relevance of iron in the pathogenesis of Parkinson's disease," Journal of Neurochemistry, vol. 118, no. 6, pp. 939-957, 2011.
103. A. Friedman, J. Galazka-Friedman, and D. Koziorowski, "Iron as a cause of Parkinson disease - a myth or a well established hypothesis?" Parkinsonism and Related Disorders, vol. 15, supplement 3, pp. S212-S214, 2009.
104. M. Politis, "Neuroimaging in Parkinson disease: from research setting to clinical practice," Nature Reviews Neurology, vol. 10, no. 12, pp. 708-722, 2014.
105. J.-A. Girault, "Signaling in striatal neurons: the phosphoproteins of reward, addiction, and dyskinesia," Progress in Molecular Biology and Translational Science, vol. 106, pp. 33-62, 2012.
106. 2+ in cell physiology and pathophysiology," Cell Calcium, vol. 28, no. 5-6, pp. 339-348, 2000.
107. L. Galluzzi, J. M. Bravo-San Pedro, and G. Kroemer, "Organelle-specific initiation of cell death," Nature Cell Biology, vol. 16, no. 8, pp. 728-736, 2014.
108. D.-F. Suen, K. L. Norris, and R. J. Youle, "Mitochondrial dynamics and apoptosis," Genes & Development, vol. 22, no. 12, pp. 1577-1590, 2008.
109. M. Manczak, T. S. Anekonda, E. Henson, B. S. Park, J. Quinn, and P. H. Reddy, "Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression," Human Molecular Genetics, vol. 15, no. 9, pp. 1437-1449, 2006.
110. X. Chen and S. D. Yan, "Mitochondrial Aβ: a potential cause of metabolic dysfunction in Alzheimer's disease," IUBMB Life, vol. 58, no. 12, pp. 686-694, 2006.
111. P. F. Pavlov, C. H. Petersen, E. Glaser, and M. Ankarcrona, "Mitochondrial accumulation of APP and Aβ: significance for Alzheimer disease pathogenesis," Journal of Cellular and Molecular Medicine, vol. 13, no. 10, pp. 4137-4145, 2009.
112. H. Du, L. Guo, F. Fang et al., "Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease," Nature Medicine, vol. 14, no. 10, pp. 1097-1105, 2008.
113. J. Yao, R. W. Irwin, L. Zhao, J. Nilsen, R. T. Hamilton, and R. D. Brinton, "Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 34, pp. 14670-14675, 2009.
114. V. S. Boyce and L. M. Mendell, "Neurotrophins and spinal circuit function," Frontiers in Neural Circuits, vol. 8, article 59, 2014.
115. B. Lu, G. Nagappan, and Y. Lu, "BDNF and synaptic plasticity, cognitive function, and dysfunction," in Neurotrophic Factors, vol. 220 of Handbook of Experimental Pharmacology, pp. 223-250, Springer, 2014.
116. M. M. Poo, "Neurotrophins as synaptic modulators," Nature Reviews Neuroscience, vol. 2, no. 1, pp. 24-32, 2001.
117. J. Burkhalter, H. Fiumelli, I. Allaman, J.-Y. Chatton, and J.-L. Martin, "Brain-derived neurotrophic factor stimulates energy metabolism in developing cortical neurons," Journal of Neuroscience, vol. 23, no. 23, pp. 8212-8220, 2003.
118. A. Markham, I. Cameron, P. Franklin, and M. Spedding, "BDNF increases rat brain mitochondrial respiratory coupling at complex I, but not complex II," European Journal of Neuroscience, vol. 20, no. 5, pp. 1189-1196, 2004.
119. J. D. Bremner, N. Fani, A. Ashraf et al., "Functional brain imaging alterations in acne patients treated with isotretinoin,"American Journal of Psychiatry, vol. 162, no. 5, pp. 983-991, 2005.
120. S. E. Wolverton and J. C. Harper, "Important controversies associated with isotretinoin therapy for acne," American Journal of Clinical Dermatology, vol. 14, no. 2, pp. 71-76, 2013.
121. R. Ballester Sánchez, B. De Unamuno Bustos, A. Agustí Mejías, and M. I. Febrer Bosch, "Increase in creatine phosphokinase and a suicide attempt during isotretinoin treatment," Anales de Pediatría, vol. 76, no. 6, pp. 365-366, 2012.
122. P. Saitta, P. Keehan, J. Yousif, B. V. Way, S. Grekin, and R. Brancaccio, "An update on the presence of psychiatric comorbidities in acne patients, part 2: depression, anxiety, and suicide," Cutis, vol. 88, no. 2, pp. 92-97, 2011.
123. D. K. Wysowski, M. Pitts, and J. Beitz, "An analysis of reports of depression and suicide in patients treated with isotretinoin,"Journal of the American Academy of Dermatology, vol. 45, no. 4, pp. 515-519, 2001.
124. Z. Nevoralová and D. Dvořáková, "Mood changes, depression and suicide risk during isotretinoin treatment: a prospective study," International Journal of Dermatology, vol. 52, no. 2, pp. 163-168, 2013.
125. G. Bjelakovic, D. Nikolova, L. L. Gluud, R. G. Simonetti, and C. Gluud, "Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis," Journal of the American Medical Association, vol. 297, no. 8, pp. 842-857, 2007.
126. G. Bjelakovic, D. Nikolova, and C. Gluud, "Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm?" PloS one, vol. 8, no. 9, Article ID e74558, 2013.
127. G. Bjelakovic, D. Nikolova, and C. Gluud, "Antioxidant supplements and mortality," Current Opinion and Clinical Nutrition and Metabolic Care, vol. 17, no. 1, pp. 40-44, 2014.
128. J. H. Humphrey, P. J. Iliff, E. T. Marinda et al., "Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality," Journal of Infectious Diseases, vol. 193, no. 6, pp. 860-871, 2006.
129. C. E. Orfanos, C. C. Zouboulis, B. Almond-Roesler, and C. C. Geilen, "Current use and future potential role of retinoids in dermatology," Drugs, vol. 53, no. 3, pp. 358-388, 1997.
130. J. Li and A. S. Lee, "Stress induction of GRP78/BiP and its role in cancer," Current Molecular Medicine, vol. 6, no. 1, pp. 45-54, 2006.
131. T. Gutiérrez and T. Simmen, "Endoplasmic reticulum chaperones and oxidoreductases: critical regulators of tumor cell survival and immunorecognition," Frontiers in Oncology, vol. 4, article 291, 2014.
132. 2+-induced inhibition of substrate oxidation," Biochimica et Biophysica Acta, vol. 1453, no. 1, pp. 41-48, 1999.
133. J. Crandall, Y. Sakai, J. Zhang et al., "13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 14, pp. 5111-5116, 2004.
134. Y. Sakai, J. E. Crandall, J. Brodsky, and P. McCaffery, "13-cis retinoic acid (accutane) suppresses hippocampal cell survival in mice," Annals of the New York Academy of Sciences, vol. 1021, pp. 436-440, 2004.
135. C. Guruvayoorappan, C. R. Pradeep, and G. Kuttan, "13-cis-Retinoic acid induces apoptosis by modulating caspase-3, bcl-2, and p53 gene expression and regulates the activation of transcription factors in B16F-10 melanoma cells," Journal of Environmental Pathology, Toxicology and Oncology, vol. 27, no. 3, pp. 197-207, 2008.
136. D. M. Bannerman, M. Grubb, R. M. J. Deacon, B. K. Yee, J. Feldon, and J. N. P. Rawlins, "Ventral hippocampal lesions affect anxiety but not spatial learning," Behavioural Brain Research, vol. 139, no. 1-2, pp. 197-213, 2003.
137. D. M. Bannerman, J. N. P. Rawlins, S. B. McHugh et al., "Regional dissociations within the hippocampus-memory and anxiety," Neuroscience and Biobehavioral Reviews, vol. 28, no. 3, pp. 273-283, 2004.
138. R. M. J. Deacon and J. N. P. Rawlins, "Hippocampal lesions, species-typical behaviours and anxiety in mice," Behavioural Brain Research, vol. 156, no. 2, pp. 241-249, 2005.
139. J. Lotharius and P. Brundin, "Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein," Nature reviews. Neuroscience, vol. 3, no. 12, pp. 932-942, 2002.
140. L. E. Salminen and R. H. Paul, "Oxidative stress and genetic markers of suboptimal antioxidant defense in the aging brain: a theoretical review," Reviews in the Neurosciences, vol. 25, no. 6, pp. 805-819, 2014.
141. G. S. Omenn, G. E. Goodman, M. D. Thornquist et al., "Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial," Journal of the National Cancer Institute, vol. 88, no. 21, pp. 1550-1559, 1996.